Beth Israel Deaconess - Plymouth Club Cancer Center is accredited with commendation as a Comprehensive Community Cancer Program by the American College of Surgeons Commission on Cancer. The Commission’s data reveals that Beth Israel Deaconess - Plymouth’s cancer program not only complies with best practices in cancer care but scores higher than state and national averages in all quality measurements for medical and radiation oncology. The following are the measurements and outcomes:
- Quality Measure: Hormone therapy is considered or administered within one year of diagnosis for women with Stage II or III hormone receptor positive breast cancer.
Beth Israel Deaconess - Plymouth is 100% compliant versus the state average of 89.1%.
- Quality Measure: For patients less than 80 years old with Stage III lymph node positive colon cancer, adjuvant chemotherapy is considered or administered within four months of a diagnosis.
Beth Israel Deaconess - Plymouth is 100% compliant versus the state average of 94.5%.
- Quality Measure: For women less than 70 years old that have a diagnosis of Stage II or III hormone receptor negative breast cancer, combination chemotherapy should be recommended or administered within four months.
Beth Israel Deaconess - Plymouth is 100% compliant versus the state average if 93.7%.
- Quality Measure: For breast cancer patients receiving breast conserving surgery, the recommendation is radiation therapy administered within one year of diagnosis for women less than 70 years old who received this surgery.
Beth Israel Deaconess - Plymouth is 100% compliant versus the state average if 93.2%.
What does being accredited by the American College of Surgeons mean to cancer patients?
- Quality care close to home
- Comprehensive care offering a range of state-of-the-art services and equipment.
- A multidisciplinary, team approach to coordinate the best cancer treatment options available.
- Access to cancer-related information and education.
- Access to patient-centered services such as psychosocial distress screening and navigation.
- Options for genetic assessment and counseling, and palliative care services.
- Ongoing monitoring and improvement of care.
- Assessment of treatment planning based on evidence-based national treatment guidelines.
- Information about clinical trials and new treatment options.
- Follow-up care at the completion of treatment, including a survivorship care plan.
- A cancer registry that collects data on cancer type, stage, and treatment results, and offers lifelong patient follow-up.
- A Nurse Navigator who coordinates the clinical, educational and supportive needs of patients.
To make an appointment or for more information, please call the Cancer Center Nurse Navigator at 508-830-2226.